Publicaciones en las que colabora con ELENA VECINO CORDERO (21)

2022

  1. Potential Tear Biomarkers for the Diagnosis of Parkinson’s Disease—A Pilot Study

    Proteomes, Vol. 10, Núm. 1

2021

  1. Plasma Rich in Growth Factors (PRGF) Increases the Number of Retinal Müller Glia in Culture but Not the Survival of Retinal Neurons

    Frontiers in Pharmacology, Vol. 12

  2. The Effect of Plasma Rich in Growth Factors on Microglial Migration, Macroglial Gliosis and Proliferation, and Neuronal Survival

    Frontiers in Pharmacology, Vol. 12

2020

  1. Optimization of a Method to Isolate and Culture Adult Porcine, Rats and Mice Müller Glia in Order to Study Retinal Diseases

    Frontiers in Cellular Neuroscience, Vol. 14

2019

  1. Effect of somatostatin on human retinal pigment epithelial cells permeability

    Experimental Eye Research, Vol. 184, pp. 15-23

2018

  1. Dexamethasone protects retinal ganglion cells but not Müller glia against hyperglycemia in vitro

    PLoS ONE, Vol. 13, Núm. 11

2017

  1. Changes in lipidomic profile of aqueous humour in Fuchs endothelial dystrophy

    Acta Ophthalmologica, Vol. 95, Núm. 7, pp. 727-732

  2. Changes in surface tension of aqueous humor in anterior segment ocular pathologies

    Vision (Switzerland), Vol. 1, Núm. 1

  3. Changes in the Lipidomic Profile of Aqueous Humor in Open-Angle Glaucoma

    Journal of Glaucoma, Vol. 26, Núm. 4, pp. 349-355

2013

  1. Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat

    Experimental Eye Research, Vol. 110, pp. 55-58

  2. The plga implant as an antimitotic delivery system after experimental trabeculectomy

    Investigative Ophthalmology and Visual Science, Vol. 54, Núm. 8, pp. 5227-5235

2012

  1. Effect of synthetic cannabinoid CB1 agonist (WIN 55212-2) and antagonist (AM 251) on intraocular pressure in rats

    Glaucoma: Etiology, Pathogenesis and Treatments (Nova Science Publishers, Inc.), pp. 147-156

  2. Morphology of retinal vessels in the optic disk in a Göttingen minipig experimental glaucoma model

    Veterinary Ophthalmology, Vol. 15, Núm. SUPPL.1, pp. 36-46

2011

  1. Aplicaciones de los cannabinoides en glaucoma

    Archivos de la Sociedad Española de Oftalmologia, Vol. 86, Núm. 1, pp. 16-23

  2. Current trends in glaucoma: What's about neuroprotection?

    Advances in Medicine and Biology (Nova Science Publishers, Inc.), pp. 149-174

  3. Los cambios ultraestructurales en la malla trabecular y el aumento de la PIO en la fisiopatogenia del glaucoma: ¿qué es antes, el huevo o la gallina?

    Archivos de la Sociedad Española de Oftalmologia, Vol. 86, Núm. 8, pp. 241-242

  4. Prevention of retinal ganglion cell swelling by systemic brimonidine in a rat experimental glaucoma model

    Clinical and Experimental Ophthalmology, Vol. 39, Núm. 8, pp. 799-807

2010

  1. Optic neuropathy in methylmalonic acidemia: The role of neuroprotection

    Journal of Inherited Metabolic Disease, Vol. 33, Núm. SUPPL. 3

2008

  1. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments

    Experimental Eye Research, Vol. 86, Núm. 5, pp. 798-806

2006

  1. Three experimental glaucoma models in rats: Comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death

    Experimental Eye Research, Vol. 83, Núm. 2, pp. 429-437